Beta Bionics Ownership | Who Owns Beta Bionics?


OverviewForecastRevenueFinancialsChartTranscripts

Beta Bionics Ownership Summary


Beta Bionics is owned by 108.81% institutional investors, 1.08% insiders. Eventide asset management is the largest institutional shareholder, holding 14.07% of BBNX shares. Eventide Gilead N is the top mutual fund, with 8.42% of its assets in Beta Bionics shares.

BBNX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBeta Bionics108.81%1.08%-9.89%
SectorHealthcare Stocks 50.53%12.40%37.07%
IndustryMedical Device Stocks49.11%12.58%38.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Eventide asset management6.25M14.07%$98.05M
Soleus capital management4.39M9.89%$68.85M
Morgan stanley4.27M9.60%$66.86M
Wellington management group llp3.90M8.99%$77.52M
Sands capital ventures3.71M8.34%$58.11M
Blackrock funding, inc. /de3.34M7.52%$52.34M
Vanguard group2.22M5.08%$67.59M
Point72 asset management2.25M5.07%$35.33M
Vanguard capital management1.78M4.01%$27.93M
Vestal point capital, lp1.60M3.60%$25.07M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pura vida investments281.16K11.91%$4.41M
Omega fund management1.32M11.11%$20.62M
Sands capital ventures3.71M9.47%$58.11M
Bruce665.70K2.82%$10.43M
Soleus capital management4.39M2.37%$68.85M
Eventide asset management6.25M1.31%$98.05M
Bridger management163.12K1.28%$1.63M
Kent lake pr125.00K1.25%$2.48M
Eversept partners, lp1.25M1.02%$19.58M
Tri locum partners lp493.34K0.95%$7.73M

Top Buyers

HolderShares% AssetsChange
Divisadero street capital management, lp1.11M0.40%1.11M
Tri locum partners lp493.34K0.95%493.34K
Goldman sachs group537.11K0.00%415.77K
Bank of america corp /de/546.65K0.00%410.44K
Jpmorgan chase703.36K0.00%396.13K

Top Sellers

HolderShares% AssetsChange
Farallon capital management595.00K0.04%-3.01M
Driehaus capital management---956.78K
Walleye capital---646.54K
Vestal point capital, lp1.60M0.59%-611.52K
12 west capital management lp---575.00K

New Positions

HolderShares% AssetsChangeValue
Tri locum partners lp493.34K0.95%493.34K$7.73M
Sixth street partners management company350.87K0.00%350.87K$5.50M
Norges bank339.30K0.00%339.30K$10.34M
Bridger management163.12K1.28%163.12K$1.63M
Kent lake pr125.00K1.25%125.00K$2.48M

Sold Out

HolderChange
Transamerica financial advisors-3.00
Root financial partners-16.00
Td private client wealth-66.00
Aster capital management (difc)-97.00
Private trust co na-209.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261373.79%48,351,844-1.97%1080.88%8925.35%35-27.08%
Mar 31, 2026126-20.25%49,182,3134.16%1211.04%68-36.45%4550.00%
Dec 31, 202563-50.78%11,567,343-76.07%260.22%45-48.28%8-61.90%
Sep 30, 202551-55.65%7,817,160-82.57%180.17%31-51.56%5-82.14%
Jun 30, 202511515.00%44,849,3148.81%1030.57%66-34.00%28-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Eventide Gilead N3.75M8.42%804.82K
Eventide Healthcare & Life Sciences I2.05M4.61%163.53K
Vanguard Total Stock Mkt Idx Inv1.27M2.86%41.70K
Vanguard MStar Total Stk Mkt Idx Invest1.27M2.83%-
Vanguard Morn Total Stk Mkt Idx Investor1.27M2.83%41.70K
iShares Russell 2000 ETF1.04M2.31%-18.43K
Bruce665.70K1.48%115.00K
Janus Henderson US Small Cap Growth MA619.11K1.39%619.11K
Vanguard Institutional Extnd Mkt Idx Tr470.37K1.05%894.00
Fidelity Small Cap Index390.93K0.87%5.81K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 26, 2026Feider Stephen Chief Financial OfficerSell$87.01K
Jun 29, 2026Feider Stephen Chief Financial OfficerSell$83.38K
Jun 29, 2026Feider Stephen Chief Financial OfficerSell$83.38K
Jun 26, 2026Feider Stephen Chief Financial OfficerSell$87.01K
Jun 24, 2026Hopman Mark Chief Commercial OfficerSell$18.88K

Insider Transactions Trends


DateBuySell
2026 Q2-14
2026 Q1-10
2025 Q4-15
2025 Q3-12
2025 Q2-15

BBNX Ownership FAQ


Who Owns Beta Bionics?

Beta Bionics shareholders are primarily institutional investors at 108.81%, followed by 1.08% insiders and -9.89% retail investors. The average institutional ownership in Beta Bionics's industry, Medical Device Stocks, is 49.11%, which Beta Bionics exceeds.

Who owns the most shares of Beta Bionics?

Beta Bionics’s largest shareholders are Eventide asset management (6.25M shares, 14.07%), Soleus capital management (4.39M shares, 9.89%), and Morgan stanley (4.27M shares, 9.60%). Together, they hold 33.56% of Beta Bionics’s total shares outstanding.

Does Blackrock own Beta Bionics?

BlackRock is not among the top 10 institutional shareholders of Beta Bionics.

Who is Beta Bionics’s biggest shareholder by percentage of total assets invested?

Pura vida investments is Beta Bionics’s biggest shareholder by percentage of total assets invested, with 11.91% of its assets in 281.16K Beta Bionics shares, valued at 4.41M$.

Who is the top mutual fund holder of Beta Bionics shares?

Eventide Gilead N is the top mutual fund holder of Beta Bionics shares, with 8.42% of its total shares outstanding invested in 3.75M Beta Bionics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools